Fluorescence resonance energy transfer analysis of CCR2-V64I and SDF1-3′A polymorphisms:: Prevalence in southern Spain HIV type 1+ cohort and noninfected population

被引:13
作者
Royo, JL
Ruiz, A
Borrego, S
Rubio, A
Sánchez, B
Nuñez-Roldán, A
Lissen, E
Antiñolo, G
机构
[1] Hosp Univ Virgen Rocio, Unidad Genet Med & Diagnost Prenatal, Seville 41013, Spain
[2] Hosp Univ Virgen Rocio, Grp Hepatitis Virica & SIDA, Seville 41013, Spain
[3] Hosp Univ Virgen Rocio, Serv Immunol, Seville 41013, Spain
关键词
D O I
10.1089/088922201750236933
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The relationship between host genotype and AIDS, as well as the different genotype frequencies observed in different populations, have become important topics in HIV research. Therefore, the development of methods that provide faster and reliable results may contribute to further development and knowledge of those topics. We present the results of genotyping SDF1-3'A and CCR2-V64I in 440 HIV-1-infected people and 100 noninfected controls from southern Spain, using a novel method based on real-time PCR with LightCycler technology and fluorescence resonance energy transfer. Frequencies obtained were 23.8% for SDF1-3'A and 9.5% for CCR2-V64I for both HIV+ cohort and general population. Both polymorphisms are in accordance with the Hardy-Weinberg equilibrium law and no differences between patients and controls have been observed.
引用
收藏
页码:663 / 666
页数:4
相关论文
共 23 条
  • [1] The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
    Bleul, CC
    Farzan, M
    Choe, H
    Parolin, C
    ClarkLewis, I
    Sodroski, J
    Springer, TA
    [J]. NATURE, 1996, 382 (6594) : 829 - 833
  • [2] The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
    Choe, H
    Farzan, M
    Sun, Y
    Sullivan, N
    Rollins, B
    Ponath, PD
    Wu, LJ
    Mackay, CR
    LaRosa, G
    Newman, W
    Gerard, N
    Gerard, C
    Sodroski, J
    [J]. CELL, 1996, 85 (07) : 1135 - 1148
  • [3] Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
    Dean, M
    Carrington, M
    Winkler, C
    Huttley, GA
    Smith, MW
    Allikmets, R
    Goedert, JJ
    Buchbinder, SP
    Vittinghoff, E
    Gomperts, E
    Donfield, S
    Vlahov, D
    Kaslow, R
    Saah, A
    Rinaldo, C
    Detels, R
    OBrien, SJ
    [J]. SCIENCE, 1996, 273 (5283) : 1856 - 1862
  • [4] Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes
    Gonzalez, E
    Bamshad, M
    Sato, N
    Mummidi, S
    Dhanda, R
    Catano, G
    Cabrera, S
    McBride, M
    Cao, XH
    Merrill, G
    O'Connell, P
    Bowden, DW
    Freedman, BI
    Anderson, SA
    Walter, EA
    Evans, JS
    Stephan, KT
    Clark, RA
    Tyagi, S
    Ahuja, SS
    Dolan, MJ
    Ahuja, SK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (21) : 12004 - 12009
  • [5] A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation
    Kostrikis, LG
    Huang, YX
    Moore, JP
    Wolinsky, SM
    Zhang, LQ
    Guo, Y
    Deutsch, L
    Phair, J
    Neumann, AU
    Ho, DD
    [J]. NATURE MEDICINE, 1998, 4 (03) : 350 - 353
  • [6] LEIONDIOS GK, 1998, SCIENCE, V279, P1228
  • [7] Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals
    Magierowska, M
    Theodorou, L
    Debré, P
    Sanson, F
    Autran, B
    Rivière, Y
    Charron, D
    Alt, F
    Costagliola, D
    [J]. BLOOD, 1999, 93 (03) : 936 - 941
  • [8] CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function
    Mariani, R
    Wong, S
    Mulder, LCF
    Wilkinson, DA
    Reinhart, AL
    LaRosa, G
    Nibbs, R
    O'Brien, TR
    Michael, NL
    Connor, RI
    Macdonald, M
    Busch, M
    Koup, RA
    Landau, NR
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (03) : 2450 - 2459
  • [9] Genetic acceleration of AIDS progression by a promoter variant of CCR5
    Martin, MP
    Dean, M
    Smith, MW
    Winkler, C
    Gerrard, B
    Michael, NL
    Lee, B
    Doms, RW
    Margolick, J
    Buchbinder, S
    Goedert, JJ
    O'Brien, TR
    Hilgartner, MW
    Vlahov, D
    O'Brien, SJ
    Carrington, M
    [J]. SCIENCE, 1998, 282 (5395) : 1907 - 1911
  • [10] Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression
    Mummidi, S
    Ahuja, SS
    Gonzalez, E
    Anderson, SA
    Santiago, EN
    Stephan, KT
    Craig, FE
    O'Connell, P
    Tryon, V
    Clark, RA
    Dolan, MJ
    Ahuja, SK
    [J]. NATURE MEDICINE, 1998, 4 (07) : 786 - 793